Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13

被引:70
作者
Avet-Loiseau, H [1 ]
Daviet, A [1 ]
Saunier, S [1 ]
Bataille, R [1 ]
机构
[1] Univ Hosp, Haematol Lab, Nantes, France
关键词
multiple myeloma; chromosome; 13; cytogenetics;
D O I
10.1046/j.1365-2141.2000.02488.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chromosome 13 abnormalities are frequently observed in multiple myeloma (MM). Several reports recently demonstrated the strong prognostic value of these abnormalities, associated with a short survival. Cytogenetic studies have shown that most of these abnormalities are complete monosomies. In order to define the common minimal deletion, we analysed a series of 234 patients with MM using fluorescence in situ hybridization (FISH) with a panel of five probes mapping along the whole chromosome 13, A chromosome 13 abnormality was observed in 98 patients (42%), 90 of whom (92%) displayed a complete monosomy. In seven of the eight remaining patients presenting partial deletions, the three probes specific for the 13q14 region were deleted, Only one patient (1%) displayed a small deletion of the D13S319 locus. In conclusion, FISH should be used for the analysis of chromosome 13 abnormalities, using probes mapping in the 13q14 region.
引用
收藏
页码:1116 / 1117
页数:2
相关论文
共 10 条
  • [1] Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
    Avet-Loiseau, H
    Li, JY
    Morineau, N
    Facon, T
    Brigaudeau, C
    Harousseau, JL
    Grosbois, B
    Bataille, R
    [J]. BLOOD, 1999, 94 (08) : 2583 - 2589
  • [2] Avet-Loiseau H, 1998, CANCER RES, V58, P5640
  • [3] IMPROVED CYTOGENETICS IN MULTIPLE-MYELOMA - A STUDY OF 151 PATIENTS INCLUDING 117 PATIENTS AT DIAGNOSIS
    LAI, JL
    ZANDECKI, M
    MARY, JY
    BERNARDI, F
    IZYDORCZYK, V
    FLACTIF, M
    MOREL, P
    JOUET, JP
    BAUTERS, F
    FACON, T
    [J]. BLOOD, 1995, 85 (09) : 2490 - 2497
  • [4] Prognostic value of numerical chromosome aberrations in multiple myeloma:: A FISH analysis of 15 different chromosomes
    Pérez-Simón, JA
    García-Sanz, R
    Tabernero, MD
    Almeida, J
    González, M
    Fernández-Calvo, J
    Moro, MJ
    Hernández, JM
    San Miguel, JF
    Orfao, A
    [J]. BLOOD, 1998, 91 (09) : 3366 - 3371
  • [5] CYTOGENETIC FINDINGS IN 200 PATIENTS WITH MULTIPLE-MYELOMA
    SAWYER, JR
    WALDRON, JA
    JAGANNATH, S
    BARLOGIE, B
    [J]. CANCER GENETICS AND CYTOGENETICS, 1995, 82 (01) : 41 - 49
  • [6] SHAUGHNESSY J, 1999, BLOOD, V94
  • [7] Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases
    Smadja, NV
    Fruchart, C
    Isnard, F
    Louvet, C
    Dutel, JL
    Cheron, N
    Grange, MJ
    Monconduit, M
    Bastard, C
    [J]. LEUKEMIA, 1998, 12 (06) : 960 - 969
  • [8] STILGENBAUER S, 1999, BLOOD, V94
  • [9] POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL OR COMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES
    TRICOT, G
    BARLOGIE, B
    JAGANNATH, S
    BRACY, D
    MATTER, S
    VESOLE, DH
    NAUCKE, S
    SAWYER, JR
    [J]. BLOOD, 1995, 86 (11) : 4250 - 4256
  • [10] Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization
    Zojer, N
    Königsberg, R
    Ackermann, J
    Fritz, E
    Dallinger, S
    Krömer, E
    Kaufmann, H
    Riedl, L
    Gisslinger, H
    Schreiber, S
    Heinz, R
    Ludwig, H
    Huber, H
    Drach, J
    [J]. BLOOD, 2000, 95 (06) : 1925 - 1930